Heron Therapeutics
HRTX
#7234
Rank
โ‚น25.70 B
Marketcap
โ‚น169.47
Share price
3.59%
Change (1 day)
79.25%
Change (1 year)

Revenue for Heron Therapeutics (HRTX)

Revenue in 2024 (TTM): โ‚น11.35 B

According to Heron Therapeutics's latest financial reports the company's current revenue (TTM) is โ‚น11.43 B. In 2023 the company made a revenue of โ‚น10.57 B an increase over the revenue in the year 2022 that were of โ‚น8.90 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Heron Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น11.35 B7.4%
2023 โ‚น10.57 B18.7%
2022 โ‚น8.90 B38.46%
2021 โ‚น6.43 B-0.57%
2020 โ‚น6.47 B-37.71%
2019 โ‚น10.39 B92.8%
2018 โ‚น5.38 B174.32%
2017 โ‚น1.96 B2160.27%
2016 โ‚น86.91 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A-100%
2011 โ‚น34.17 M-41.41%
2010 โ‚น58.32 M-0.7%
2009 โ‚น58.73 M219.34%
2008 โ‚น18.39 M
2005 โ‚น0.24 B14.14%
2004 โ‚น0.21 B-3.91%
2003 โ‚น0.22 B-16.59%
2002 โ‚น0.26 B25.27%
2001 โ‚น0.21 B34.76%
2000 โ‚น0.15 B-82.92%
1999 โ‚น0.91 B9.27%
1998 โ‚น0.84 B17.7%
1997 โ‚น0.71 B5.83%
1996 โ‚น0.67 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น126.50 B 1,005.83%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น57.91 B 406.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.81 B-31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.19 B-2.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.13 B-11.40%๐Ÿ‡บ๐Ÿ‡ธ USA